Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in chronic neuropathic pain
NCT06731335Phase 2Recruiting
- Sponsor
- Unity Health Toronto
- Start
- Mar 2025
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in chronic neuropathic pain, sponsored by Unity Health Toronto. Started Mar 2025; status: recruiting.
02
Drugs
psilocybin
03
Conditions
chronic neuropathic pain
Beyond the preview
Go deeper on NCT06731335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06731335.